These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9041760)

  • 1. [Clinical experience of automated double filtration plasmapheresis].
    Lee CT; Chuang FR; Hsu KT; Lam KK; Liao SC; Liu CC; Chen JB; Jang SW; Chien YS; Pan HH
    Changgeng Yi Xue Za Zhi; 1996 Dec; 19(4):313-9. PubMed ID: 9041760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience in the treatment of myasthenia gravis with double filtration plasmapheresis.
    Chuang YC; Lee CT; Chen JB; Chee EC
    Chang Gung Med J; 2000 Feb; 23(2):80-6. PubMed ID: 10835802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolysis in double-filtration plasmapheresis.
    Yeh JH; Chen WH; Chiu HC; Bai CH
    Am J Clin Pathol; 2007 Jan; 127(1):76-80. PubMed ID: 17145631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of double-filtration plasmapheresis.
    Yeh JH; Chen WH; Chiu HC
    Transfusion; 2004 Nov; 44(11):1621-5. PubMed ID: 15504168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis-related hypotension.
    Yeh JH; Chiu HC
    Artif Organs; 2000 Sep; 24(9):705-9. PubMed ID: 11012540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double filtration plasmapheresis in the treatment of inflammatory polyneuropathy.
    Chiu HC; Chen WH; Yeh JH
    Ther Apher; 1997 May; 1(2):183-6. PubMed ID: 10225768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmapheresis in neurology -- personal experience].
    Załeska B; Domzał T; Korsak J
    Neurol Neurochir Pol; 1994; 28(2):167-74. PubMed ID: 8047226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic study of serial double-filtration plasmapheresis.
    Yeh JH; Chen WH; Chiu HC
    J Clin Apher; 2002; 17(1):33-7. PubMed ID: 11948704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of the different vascular accesses used for double-filtration plasmapheresis.
    Yeh JH; Chen WH; Chiu HC
    J Clin Apher; 2001; 16(3):125-9. PubMed ID: 11746538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
    Liu LL; Li XL; Wang LN; Yao L; Fan QL; Li ZL
    J Clin Apher; 2011; 26(4):174-80. PubMed ID: 21462239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
    Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
    Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function study of myasthenia-gravis patients treated with double-filtration plasmapheresis.
    Chiu HC; Yeh JH; Chen WH
    J Clin Apher; 2003; 18(3):125-8. PubMed ID: 14569603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation abnormalities in serial double-filtration plasmapheresis.
    Yeh JH; Chiu HC
    J Clin Apher; 2001; 16(3):139-42. PubMed ID: 11746541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action.
    Zhang L; Liu J; Wang H; Zhao C; Lu J; Xue J; Gu Y; Hao C; Lin S; Lv C
    J Clin Neurosci; 2014 Sep; 21(9):1570-4. PubMed ID: 24814857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants.
    Yeh JH; Lee MF; Chiu HC
    J Clin Apher; 2003; 18(1):32-6. PubMed ID: 12717791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
    Huo JT; Long HL; Luo X; Xu JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.
    Seishima M; Shibuya Y; Kato G; Aoki T
    Ther Apher Dial; 2009 Jun; 13(3):229-31. PubMed ID: 19527471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a non-haemophilic patient with inhibitor to factor VIII by double-filtration plasmapheresis.
    Sunagawa T; Uezu Y; Kadena K; Tokuyama K; Kinjo F; Saito A
    Br J Haematol; 1999 Mar; 104(3):465-7. PubMed ID: 10086780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.